Page last updated: 2024-09-03
gefitinib and edetic acid
gefitinib has been researched along with edetic acid in 2 studies
Compound Research Comparison
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (edetic acid) | Trials (edetic acid) | Recent Studies (post-2010) (edetic acid) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 27,553 | 629 | 3,970 |
Protein Interaction Comparison
Protein | Taxonomy | gefitinib (IC50) | edetic acid (IC50) |
---|---|---|---|
Amyloid-beta precursor protein | Homo sapiens (human) | 7.7 | |
Beta-lactamase VIM-1 | Pseudomonas aeruginosa | 9.3 |
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Beijnen, JH; Durmus, S; Schellens, JH; Schinkel, AH; Sparidans, RW | 1 |
Reviews
1 review(s) available for gefitinib and edetic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
1 other study(ies) available for gefitinib and edetic acid
Article | Year |
---|---|
Liquid chromatography-tandem mass spectrometric assay for the PARP inhibitor rucaparib in plasma.
Topics: Acetonitriles; Animals; Area Under Curve; Calibration; Chromatography, Liquid; Edetic Acid; Female; Gefitinib; Indoles; Mice; Poly(ADP-ribose) Polymerase Inhibitors; Protein Kinase Inhibitors; Quality Control; Quinazolines; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |